Skip to main content

Search form

You are here

Funded Projects

A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel on Ablation of Upper Urinary Tract Urothelial Carcinoma
A Phase 3 prospective, randomized, multicenter, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-Matched, living donor kidney transplants
A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biopsy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance(proSPECT-AS)
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR PREVENTION OF DELAYED GRAFT FUNCTION IN RECIPIENTS OF A DONATION AFTER BRAIN DEATH OLDER DONOR KIDNEY TRANSPLANT (ReGIFT)
A PHASE Ib/II, OPEN-LABEL STUDY OF THE SAFETY AND PHARMACOLOGY OF ATEZOLIZUMAB ADMINISTERED WITH OR WITHOUT BACILLE CALMETTE-GUÉRIN IN PATIENTS WITH HIGH-RISK NON¿MUSCLEINVASIVE BLADDER CANCER
A Phase II study of Sporadic Angiomyolipomas (AMLs) Growth Kinetics while on Everolimus Therapy
A Phase II, Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study of GSK1278863, a HIF-Prolyl Hydroxylase Inhibitor, to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair
A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder C
A Platform for Real-time Drug Profiling of Patient-Derived Melanomas
A point-of-care, biomarker-based test to predict non-healing in chronic wounds
A Post-Market, Prospective, Multicenter, Single-Arm Trial of XenMatrix¿ AB Surgical Graft in All CDC Wound Class Ventral or Incisional Midline Hernias
A Prospective Observational Cohort Study of Patients with Castration Resistant Prostate Cancer
A Prospective Pilot Study to Examine the Involvement of apoE Gene Variants in Intracranial Hemorrhage in LVAD Patients
A prospective randomized, double-blind, sham-controlled, multicenter, Phase 3 study of OTO- 201 given as a single intratympanic injection for intra-operative treatment of middle ear effusion in pediatric subjects requiring tympanostomy tube placement
A Prospective, Multicenter, Non-Blinded, Non-Randomized Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery
A Prospective, Open-Label, Long-Term Safety and Efficacy of Teduglutide
A Prospective, Phase 3, Multi-Center, Single-Arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA-7.3 (18F) PET Ligand in Men with Newly Diagnosed Prostate Cancer
A Prospective, Randomized, Controlled, Unblinded, Multi-Center ClinicalTrial to Evaluate the HeartWare Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure
A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 2b study of OTO-104 given as a single intratympanic injection in subjects with unilateral Menieres disease (104-201102)
A prospective, single arm, multi-center clinical study to evaluate the thoracotomy implant technique(Heartware 006)

Pages